Back to Trades
Giraudo Bryan
DirectorCIK 0001740847
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 5
- Buy transactions
- 0
- Sell transactions
- 4
- Companies
- 2
- Active
- 2025–2026
Across 5 filings between 2025–2026, Giraudo Bryan, Director, has disclosed $14.8M in transactions — spread across 2 companies. Their disclosed trades are heavily weighted toward selling — $0 in buys and $5.9M in sells. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
5 loaded
| May 11 | PTGX Protagonist Therapeutics, Inc | Giraudo Bryan | Director | Sell | $5.9M |
| Mar 20 | GOSS Gossamer Bio, Inc. | Giraudo Bryan | COO/CFO | Award | $6.1M |
| Jan 6 | PTGX Protagonist Therapeutics, Inc | Giraudo Bryan | Director | Grant | $328.0K |
| Jan 5 | GOSS Gossamer Bio, Inc. | Giraudo Bryan | COO/CFO | Grant | $2.0M |
| Oct 2 | GOSS Gossamer Bio, Inc. | Giraudo Bryan | COO/CFO | Grant | $0 |
5 filings